An 18-year survivor of neuroblastoma is believed to represent the longest reported remission to date in a patient treated with chimeric antigen receptor (CAR) T cell therapy.
Read More
Researchers relate their journey to finding a promising method to address CAR T cell challenges in treating solid tumors.
Read More
A closer look at how BPA and MyChart have been instrumental in helping connect with a diverse patient population in clinical research.
Read More
A clinical trial has the potential to improve the prognosis for patients with pancreatic adenocarcinoma.
Read More
Clinical trial of novel personalized CAR T cell immunotherapy provides clues into what mediated exceptional patient recovery.
Read More
About one of every five breast cancers presents with high levels of HER2 proteins. Known as HER2-positive breast cancer, these tumors typically show an aggressive
Read More
Neuroblastoma is the most common extracranial solid cancer in children, and patients with high-risk disease are challenging to treat. In April, during the annual meeting of
Read More
When it comes to cancer, one-size-does-not-fit-all. “One of the challenges that we have when taking care of patients with bladder cancer is that from one
Read More
Doctors, patients, and researchers are frustrated when a new healthcare approach works well in a study, but then has disappointing results in the “real world.”
Read More
T cell therapies have demonstrated encouraging results and benefits in patients with lymphoma resistant to chemotherapy, but, despite these advances, a large number of patients
Read More